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Levels of Ag8 in cultural media varied
considerably depending on periods of cultivation
of bacteria. Additionally, the level of Ag8 varied
among strains of B. pseudomallei and B. mallei.
Among 61 strains of B. pseudomallei from the
museum collection (most of which were isolated
in Southeast Asia and northern Australia), three
had increased ability to produce Ag8. These
strains had been isolated from clinical specimens
(blood, abscesses of hospitalized melioidosis
patients) in Vietnam. The strains gave results
typical of B. pseudomallei species in all routine
serologic tests (agglutination test, immunofluo-
rescence assay, immunodiffusion test). In
contrast, the B. pseudomallei glanders agent (16
strains from the museum collection) had reduced
ability for Ag8 production; ELISA titers of Ag8
were a thousandfold less in culture fluids in these
strains.
The ELISA technique not only facilitates
diagnosis of disease but also provides a rational
basis for selecting strains for vaccine production.
It also has considerable utility for studying the
pathogenicity of B. pseudomallei.
Natalja P. Khrapova, Nikolay G. Tikhonov,
Yelena V. Prokhvatilova
Volgograd Antiplague Research Institute,
Volgograd, Russia
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To the Editor: Recognizing disease emergence as
a paradigm uniquely influenced by human
activity demands a reevaluation of traditional
disease surveillance systems. Part of a surveil-
lance program should be focused on the areas of
human activity where disease emergence is most
likely to occur. A system that monitors areas
known to be involved in disease emergence, such
as development projects, agriculture, climate,
and refugee movements, may greatly increase
our ability to detect and prevent outbreaks.
Large development projects entail ecologic
upheavals that can facilitate disease emergence.
Construction of a dam in 1987 in Mauritania
resulted in increased mosquito breeding sites and
in an explosion in the mosquito population;
epidemics of Rift Valley fever quickly followed
(1). The Southeastern Anatolia Irrigation Project
on the Euphrates and Tigris Rivers in Turkey,
which will provide irrigation for 1.7 million
hectares, has already increased malaria and
leishmaniasis cases in the local population (2).
The massive Three Gorges Dam Project on the
Yangtze River in China, which will create a
reservoir 760 km long, must be evaluated for its
impact on local disease. With knowledge of
endemic diseases and their reservoirs and vectors
in these areas of ecologic change, public health
workers can anticipate disease epidemics and
implement prevention measures.
Incorporating climate predictions into a
disease surveillance system would supplement
resources in an area known to affect disease
emergence. The U.S. Agency for International
Development’s (USAID) Famine Early Warning
System monitors the African continent for two
major factors implicated in emergence: tempera-
ture and precipitation. Focused on countries at
high risk for food shortages and famine, the early
warning system is an example of a predictive and
preventative surveillance system. Precipitation,
temperature, and plant health data from
satellites are evaluated as indicators of crop
failure. These data are supplemented by
information from field representatives who
directly observe agricultural production. USAID’s
system and other global monitoring systems can
provide a base level of surveillance that can add
to our knowledge of climatologic influence on
disease emergence.
The beginning of the Zairian refugee crisis in
1994 illustrates the need for surveillance among
refugee populations. In July 1994, 500,000 to
800,000 Rwandan Hutus fled into the North Kivu
region of Zaire. In the month between July 14 and
August 14, 48,347 of these refugees died,338 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
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predominantly of infectious diseases (3). Similar
infectious disease epidemics occurred among
Kurdish refugees in 1991 (4), Somali refugees in
1992 (5), and Burundian refugees in Rwanda in
1993 (6). In the wake of intense political, social, or
physical disruption, the movement of large
numbers of people creates ideal conditions for
disease outbreaks. When moving into new areas,
refugees may not be equipped immunologically
against endemic diseases. Most refugee camps
are overcrowded, with inadequate sanitation or
medical care (7). Refugees often have severe
shock or stress, which in combination with poor
nutrition, weakens immune defenses. Therefore,
refugee populations are extremely vulnerable
and should be closely monitored for infectious
disease outbreaks. The United Nations High
Commissioner for Refugees, the International
Rescue Committee, and the Human Rights
Watch can provide rapid notification about
disease emergence in refugee populations.
Recognizing human involvement as a com-
mon critical factor in emergence creates the
possibility of refining international disease
surveillance. The Centers for Disease Control
and Prevention, the World Health Organization,
and national governments should foster relation-
ships with organizations already placed to
provide disease emergence information in
populations and locations implicated in disease
emergence. These relationships will increase the
scope and efficiency of our efforts to prevent
human disease.
Harley Feldbaum
Wesleyan University, Middletown,
Connecticut, USA
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Provide a Context for Disease
Emergence
To the Editor: When a disease emerges, the trend
is to assume that another important and
spreading infection is about to devastate humans
or animals. Some qualification of the term
“emergence” is needed to put emerging diseases
into a context for each target species. There may
be a cause for alarm and further action or,
alternatively, no real change except in knowl-
edge. In Australia, for example, an old disease
“emerged” in a new area, while in another, a
disease new to the continent emerged. The two
disease agents were Ross River virus (which
causes fever and polyarthritis in humans) and
bluetongue virus (which often causes fatal
disease in sheep). Both causative viruses are
insect-borne.
Ross River virus is probably of very ancient
lineage as an infection transmitted between
marsupials and indigenous mosquitoes and was
on the Australian continent long before humans
first entered (some tens of thousands of years
ago). In 1975, the infection was not known to
occur in Tasmania, the state separated from the
Australian mainland by a wide stretch of sea. In
that year, my group detected a clear-cut
seroconversion to Ross River virus in sentinel
cows in northern Tasmania (1). Cooperative
investigations found antibody-positive sera first
in marsupials and then in persons who had never
left Tasmania. The existing clinical condition of
polyarthritis was linked to Ross River virus only
after the causative virus was recognized
indirectly (2). The marsupial populations of
mainland Australia and Tasmania were continu-
ous until the seas rose at the end of the last ice
age. Ross River disease had emerged in
Tasmania, but only from obscurity.
Bluetongue viruses occur widely in southern
and eastern Asia (3). This general picture has
been established only since the discovery of
bluetongue virus in Australia. Overt disease
occurs in sheep on the fringes of the endemic-
disease region and in susceptible sheep imported
into various countries within the region (3). In